Skip to main content

Find Clinical Trials

Home
Conditions
Relapsing-Remitting Multiple Sclerosis

Clinical trial condition

Relapsing-Remitting Multiple Sclerosis

Explore clinical trials studying Relapsing-Remitting Multiple Sclerosis. Study availability and eligibility vary by location and protocol.

98 public trials 4 recruiting studies

Refine in advanced search Browse all conditions

Relapsing-Remitting Multiple Sclerosis trial results

Completed

Behavior and Activity Monitoring in MS

NCT03244696

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Behavior, +15 more
Locations: Department of Psychology, The Ohio State University Columbus, Ohio, United States

View Trial Details

Completed

Efficacy and Safety of BCD-063 and Copaxone-Teva in Patients With Relapsing-Remitting Multiple Sclerosis

NCT02753088

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations: Not specified

View Trial Details

Completed

Sunphenon Epigallocatechin-gallate (EGCg) in Relapsing-remitting Multiple Sclerosis (SuniMS Study)

NCT00525668

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +10 more
Locations: NeuroCure Clinical Research Center, Charite University, Berlin Berlin, Germany

Outpatient Clinic for Neuroimmunology at the ECRC, Charite University, Berlin Berlin, Germany

View Trial Details

Completed

A Pilot Trial to Test the Feasibility of Prolonged Fasting and Ketogenic Diet in Relapsing-remitting Multiple Sclerosis

NCT01538355

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +11 more
Locations: Charité-Universitätsmedizin Berlin, Germany

View Trial Details

Completed

Patient Research Cohort: Rapidly Evolving Multiple Sclerosis

NCT01044576

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +12 more
Locations: Imperial College NHS Trust London, United Kingdom

View Trial Details

Completed

BG00012 Monotherapy Safety and Efficacy Extension Study in Multiple Sclerosis (MS)

NCT00835770

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +10 more
Locations: Research Site Birmingham, Alabama, United States

Research Site Huntsville, Alabama, United States

research Site Mesa, Arizona, United States

Research Site Phoenix, Arizona, United States

View all 246 locations

View Trial Details

Completed

CLARITY Extension Study

NCT00641537

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations: Research Site Boulder, Colorado, United States

Research Site Atlanta, Georgia, United States

Research Site Chicago, Illinois, United States

Research Site Northbrook, Illinois, United States

View all 116 locations

View Trial Details

Completed

A Study Evaluating the Effectiveness of Tecfidera (Dimethyl Fumarate) on Multiple Sclerosis (MS) Disease Activity and Patient-Reported Outcomes

NCT01930708

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations: Research Site Innsbruck, Austria

Research Site Klagenfurt, Austria

Research Site Linz, Austria

Research Site Salzburg, Austria

View all 90 locations

View Trial Details

Completed

Glatiramer Acetate (Copaxone®) Study to Follow Participants From the First Original Study for Safety and Effectiveness

NCT00203021

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations: Teva Investigational Site 009 Los Angeles, California, United States

Teva Investigational Site 004 Los Angeles, California, United States

Teva Investigational Site 008 New Haven, Connecticut, United States

Teva Investigational Site 005 Baltimore, Maryland, United States

View Trial Details

Completed

Autologous Mesenchymal Stromal Cells for Multiple Sclerosis

NCT02495766

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +12 more
Locations: Hospital Vall Hebron Barcelona, Spain

View Trial Details